Company

Takeda Pharmaceutical Company

2022

Quick facts

5,734,000

Emissions (ton CO₂e)

29,990

Revenue (M USD)

191.2

Intensity (t CO₂e / M USD)

Ambition & Development

In 2022, Takeda Pharmaceutical Company reported a total of 5,734,000 ton CO₂e, and a net revenue of 29,990 M USD, resulting in a emissions intensity of 191.2 t CO₂e / M USD.

Targets

Base year:

2016

Target year:

2025

Reduction:

0.4

Classification:

1.5°C

Takeda Pharmaceutical Company commits to reduce absolute scope 1 and 2 GHG emissions 40% by FY2025 from a FY2016 base year.

Source: Science Based Target initative

Emissions, Revenue & Intensity

Emissions, Target & Trend

Revenue	2022
Net Revenue (M USD)	29,990
Revenue Source

Emissions Overview	2022
Total Emissions - Market Based (t CO₂e)
Emissions Intensity (t CO₂e / M USD)	191.2
Cradle-to-gate Intensity (t CO₂e / M USD)	191.2

Emissions Details	2022
Scope 1	277,000
Scope 2
Scope 2 - Location Based
Scope 2 - Market Based
Scope 2 - Not specified	291,000
Scope 3	5,166,000
Upstream Emissions
1. Purchased goods and services
2. Capital goods
3. Fuel- and energy-related activities
4. Upstream transportation and distribution
5. Waste generated in operations
6. Business travel
7. Employee commuting
8. Upstream leased assets
Downstream Emissions
9. Downstream transportation and distribution
10. Processing of sold products
11. Use of sold products
12. End-of-life treatment of sold products
13. Downstream leased assets
14. Franchises
15. Investments
Total Emissions	5,734,000
Emission Source

Open Sustainability Index

Licensed under CC BY-SA 4.0